SI
MEDP icon

Stephens Inc’s Medpace MEDP Stock Holding History

Stephens Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
464
-63
-12% -$29.1K ﹤0.01% 1153
2026
Q1 		$253K Buy
527
+18
+4% +$9.22K ﹤0.01% 1109
2025
Q4 		$286K Sell
509
-8
-2% -$4.54K ﹤0.01% 1059
2025
Q3 		$266K Buy
+517
New +$226K ﹤0.01% 1102
2025
Q2 		– Sell
-711
Closed -$217K – 1309
2025
Q1 		$217K Sell
711
-41
-5% -$13.8K ﹤0.01% 1119
2024
Q4 		$250K Buy
752
+35
+5% +$11.9K ﹤0.01% 1086
2024
Q3 		$239K Buy
717
+101
+16% +$38.4K ﹤0.01% 1123
2024
Q2 		$254K Buy
616
+239
+63% +$94.6K ﹤0.01% 1067
2024
Q1 		$152K Buy
377
+191
+103% +$67.2K ﹤0.01% 1194
2023
Q4 		$57K Buy
186
+102
+121% +$27.5K ﹤0.01% 1201
2023
Q3 		$20.3K Buy
84
+13
+18% +$3.33K ﹤0.01% 1195
2023
Q2 		$17.1K Buy
71
+54
+318% +$11.2K ﹤0.01% 1217
2023
Q1 		$3.2K Buy
+17
New +$3.52K ﹤0.01% 1188
2022
Q1 		– Sell
-432
Closed -$94K – 1364
2021
Q4 		$94K Buy
432
+24
+6% +$5.03K ﹤0.01% 1262
2021
Q3 		$77K Buy
+408
New +$74.4K ﹤0.01% 1280

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Stephens Inc's MEDP Position: Q2 2026 in Review

Stephens Inc reduced its Medpace (MEDP) stake by 12% in Q2 2026, selling an estimated $29.1K and leaving 464 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Stephens Inc first reported a position in MEDP in Q3 2021 and has held it in 15 quarters since. The position peaked at $286K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Stephens Inc held 464 shares of Medpace worth $246K as of Q2 2026.
  • Stephens Inc sold 63 Medpace shares in Q2 2026, an estimated $29.1K.
  • Medpace made up ﹤0.01% of Stephens Inc's portfolio in Q2 2026, its #1153 holding.
  • Stephens Inc first reported a position in Medpace in Q3 2021 and has held it in 15 quarters since.
  • Stephens Inc's Medpace position peaked at $286K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.